Cargando…
Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy
Corticobasal degeneration (CBD) is a neurodegenerative disorder affecting movement and cognition, definitively diagnosed only at autopsy. Here, we conduct a genome-wide association study (GWAS) in CBD cases (n=152) and 3,311 controls, and 67 CBD cases and 439 controls in a replication stage. Associa...
Ejemplares similares
-
Clinical and pathologic features of cognitive-predominant corticobasal degeneration
por: Sakae, Nobutaka, et al.
Publicado: (2020) -
MAPT subhaplotypes in corticobasal degeneration: assessing associations with disease risk, severity of tau pathology, and clinical features
por: Valentino, Rebecca R., et al.
Publicado: (2020) -
Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures
por: Valentino, Rebecca R., et al.
Publicado: (2020) -
Corticobasal degeneration and corticobasal syndrome: A review
por: Constantinides, Vasilios C., et al.
Publicado: (2019) -
Rheumatoid arthritis-associated polymorphisms are not protective against Alzheimer's disease
por: Simmons, Christopher R, et al.
Publicado: (2011)